Get the Stockscreener App
2.54
17.59%
0.38
After Hours:
2.49
-0.05
-1.97%
Rafael Holdings Inc stock is traded at $2.54, with a volume of 384.25K.
It is up +17.59% in the last 24 hours and up +96.90% over the past month.
Rafael Holdings Inc is a biotechnology firm that develops pharmaceuticals and invests in clinical and early-stage companies in pharmaceuticals and medical devices. Trappsol Cyclo is in Phase 3 trials for Niemann-Pick Disease Type C1. The company focuses on completing these trials, seeking regulatory approval, and commercializing the product. It also invests in portfolio companies including Cyclo, LipoMedix, Barer, Rafael Medical Devices, Cornerstone, and Day Three, targeting therapeutics for unmet medical needs. The business operates through three segments: Healthcare, Infusion Technology, and Real Estate. Operations are based in the United States and Israel.
See More
Previous Close:
$2.16
Open:
$2.14
24h Volume:
384.25K
Relative Volume:
3.45
Market Cap:
$132.08M
Revenue:
$1.16M
Net Income/Loss:
$-32.23M
P/E Ratio:
-3.2357
EPS:
-0.785
Net Cash Flow:
$-27.90M
1W Performance:
+31.61%
1M Performance:
+96.90%
6M Performance:
+106.50%
1Y Performance:
+27.00%
1-Day Range:
$2.07
$2.5799
1-Week Range:
$1.72
$2.5799
52-Week Range:
$1.12
$2.6494
Rafael Holdings Inc Stock (RFL) Company Profile
Name
Rafael Holdings Inc
Sector
Industry
Phone
212-658-1450
Address
520 BROAD STREET, NEWARK
Compare RFL vs CBRE, BEKE, JLL, CSGP, COMP
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
RFL
Rafael Holdings Inc
|
2.54 | 112.32M | 1.16M | -32.23M | -27.90M | -0.785 |
CBRE
Cbre Group Inc
|
135.47 | 39.28B | 42.17B | 1.43B | 897.00M | 4.3837 |
BEKE
Ke Holdings Inc Adr
|
16.12 | 18.43B | 12.67B | 477.84M | 279.43M | 0.4156 |
JLL
Jones Lang Lasalle Inc
|
302.75 | 13.84B | 26.76B | 894.10M | 1.03B | 18.60 |
CSGP
Costar Group Inc
|
31.97 | 13.08B | 3.41B | 25.30M | 165.00M | 0.0602 |
COMP
Compass Inc
|
9.42 | 6.83B | 6.96B | -58.70M | 203.30M | -0.1082 |
Rafael Holdings Inc Stock (RFL) Latest News
RFL Q1 2025 Earnings: Net Loss of $0.37 Per Share, Stock Rises 5.66%Earnings Beat Alert - newsline.com
RFL Q1 2025 Earnings: Loss Per Share of -$0.37 as Stock Rises 5.66%Net Income Trends - newsline.com
RFL Q1 2025 Earnings: Net Loss of $0.37 per Share as Holding Company Maintains Strategic FocusMargin Expansion Trends - newsline.com
Rafael Holdings Releases Q3 2026 Financial Results - AlphaStreet
Rafael Flat on Q3 Figures - TradingView
Rafael Holdings narrows Q3 loss to $(0.08) per share - scanx.trade
Rafael Holdings, Inc. 3Q 2026: Revenue $179K, EPS ($0.08) — 10-Q Summary - TradingView
Rafael Holdings (NYSE: RFL) posts Q3 2026 loss as it funds Trappsol Cyclo trial - Stock Titan
Rafael Holdings reports Q3 FY2026 net loss of $4.2M; cash $30.5M; NDA expected H2 2026 - TradingView
RFL: Pivotal Phase 3 trial completed; NDA submission and commercial transition expected in H2 2026 - TradingView
[8-K] Rafael Holdings, Inc. Reports Material Event - Stock Titan
Rafael Holdings Reports Third Quarter Fiscal 2026 Financial Results - The Manila Times
Rafael Holdings, Inc. Reports Q3 Fiscal 2026 Financial Results and Progress on Phase 3 TransportNPC™ Trial - Quiver Quantitative
BRIEF-Rafael Holdings Q3 Net Income USD -2.899 Million - TradingView
Rare disease trial milestone: Rafael plans 2026 NPC drug filing - Stock Titan
Rafael Holdings (RFL) completes Phase 3 TransportNPC trial - grafa.com
Rafael Holdings, Inc. Announces Completion Of Last Patient Last Visit For Pivotal Phase 3 TransportNPC Study Evaluating Trappsol Cyclo For The Treatment Of Niemann-Pick Disease Type C - marketscreener.com
Rafael Holdings Completes Pivotal Phase 3 TransportNPC Study - TipRanks
Rafael Holdings completes phase 3 NPC disease trial enrollment - Investing.com
Rafael Holdings completes phase 3 NPC disease trial enrollment By Investing.com - Investing.com Canada
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 TransportNPC™ Study Evaluating Trappsol® Cyclo™ for the Treatment of Niemann-Pick Disease Type C - The Manila Times
Rafael Holdings Announces Completion of Last Patient Last Visit for Pivotal Phase 3 ... - Enidnews.com
Rafael Holdings Nears Finish Line in Rare Disease Race, Eyes Commercial Future - BriefGlance
Rafael Holdings concludes Phase 3 TransportNPC™ trial for NPC - grafa.com
RFL Q1 2025 Earnings: Net Loss Reported as Company Advances Strategic InitiativesQuarterly Earnings - newsline.com
Rafael Holdings (RFL) Surges 5% as Momentum Builds; Key Resistance in SightStop Hunt - newsline.com
RFL Q1 2025 Earnings: Widening Losses Amid Continued Development StageForward Guidance Trends - newsline.com
RFL Q1 2025 Earnings: Wider Loss Stems From Continued Clinical InvestmentAnalyst Consensus Shift - The Legal Advocate
Rafael Holdings (RFL) Q1 2025 Earnings: Net Loss of $0.37 Per Share as Stock Slightly DeclinesFinancial Health Score - The Legal Advocate
RFL Q1 2025 Earnings: Narrowing Losses Amid No Revenue – Stock Edges HigherDividend Increase Stocks - newsline.com
RFL Q1 2025 Earnings: Net Loss of $0.37 per Share as Pre‑Revenue Development ContinuesEarnings Surprise Report - The Legal Advocate
Rafael Holdings (RFL) Edges Higher: Testing Key Resistance After 2.19% GainLinear Regression - The Legal Advocate
Rafael Holdings Inc. Q1 2025 Earnings: Negative EPS Persists as Stock Shows Modest GainsGuidance Revision Trend - The Legal Advocate
Rafael Holdings Inc. (RFL) Q1 2025 Earnings: Net Loss Widens Amid Minimal Operating Revenue - newsline.com
Rafael Holdings (RFL) Shows Modest Uptick as Shares Test Key Resistance LevelsPut Flow Alert - The Legal Advocate
Rafael Holdings (RFL) Sees Modest Uptick, Testing Key Resistance at $1.41Community Watchlist Picks - Newser
Rafael Holdings (RFL) Q1 2025 Results Meet Expectations — Revenue $N/ARevenue Beat Analysis - The Legal Advocate
Ceasefire on paper, war in the courts: Why the Lopez feud is far from over - Rappler
MSN Money - MSN
TradingKey - TradingKey
Piki sues Lopez majority bloc for contempt of court - Inquirer.net
Armani Group Partners With Rafael Nadal’s Firm on Luxury Residences in Marbella - Yahoo Finance Singapore
CAEP (CantorEquity) reports quarterly earnings with key metrics pending; market monitors for additional disclosure.Book Value Growth - The Legal Advocate
CYTH Stock Insider Trading Activity - Quiver Quantitative
Floor & Decor Holdings President Acquires 39% More Stock - Yahoo Finance
How Rafael Holdings (RFL) performance reflects its true potential (Institutional Demand) 2026-05-07Social Buy Zones - Newser
Businesses on the move in Marin, Napa, Solano, Sonoma and Mendocino counties: April 30 report - The Press Democrat
Ekso Bionics: Q1 Earnings Snapshot - KTVB
Rafael Holdings Insider Ups Holding By 1,810% During Year - Yahoo Finance
RFL Price Today: Rafael Holdings, Inc. Stock Price, Quote & Chart | MEXC - MEXC Exchange
This R.E.A. Holdings Insider Increased Their Holding By 34% Last Year - Yahoo Finance
Rafael Holdings Inc Stock (RFL) Financials Data
Revenue
Net Income
Cash Flow
EPS
0.00%
0.71%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):